Table 1. Clinical characteristics of 66 patients with lung adenocarcinoma.

Variable	Total cases	REV-ERBα downregulation in LUAD (%)
Gender
Male	40	30 (75.0)
Female	26	24 (92.3)
T stage
Tx	1	0 (0.0)
T1	12	7 (58.3)
T2	20	16 (80.0)
T3	31	29 (93.5)
T4	2	2 (100.0)
Age
≤50	16	14 (87.5)
>50	50	40 (80.0)
M stage
Mx	3	1 (33.3)
M0	58	48 (82.8)
M1	5	5 (100.0)
EGFR mutation
No	30	22 (73.3)
Yes	36	32 (88.9)

LUAD, lung adenocarcinoma; EGFR, epidermal growth factor receptor.